In addition, the elevated SPP1 and HMOX1 expression levels were found to be associated with more advanced histological subtypes of glioma, specifically when comparing GBM to astrocytoma, oligodendroglioma and oligoastrocytoma (p < 0.001, Figure 3C). The gene discussed is HMOX1; the disease is central nervous system cancer.